Krystexxa 8 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB26FL5T9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,470
Award facts
- Contract value 100% obligated
- $87,470.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,470 to AmerisourceBergen Drug Corp for the supply of Krystexxa 8 mg/ml vials. The contract, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, utilizes firm fixed price terms and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending through December 2026, which serves as the primary contracting mechanism for AmerisourceBergen's federal pharmaceutical distribution to military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA, delivering a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Krystexxa, a specialty medication used in the treatment of chronic gout, represents one component of the company's critical pharmaceutical support services to Defense Health Agency customers and other federal healthcare systems. The DLA Troop Support Medical IDC represents a strategic approach to global pharmaceutical procurement, enabling flexible and responsive delivery of medical supplies to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FL5T9?
SPE2DB26FL5T9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FL5T9 worth?
The government has obligated $87,470 on SPE2DB26FL5T9.
Is contract SPE2DB26FL5T9 an order under another contract?
Yes. SPE2DB26FL5T9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5T9 competed?
The extent of competition for SPE2DB26FL5T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award